Q&A – June 20, 2025

Q&A – June 20, 2025

Dear FDA Matters subscribers–There was one FDA Matters column this week. Alice, Humpty Dumpty and the New Administration, in which I explored the meaning of radical transparency, gold-standard science, and ultra-processed foods.I also posted a comment (here) on...
Q&A – June 20, 2025

Steven on User Fees in Roll Call Daily

Targeting FDA user fees would leave agency gutted, experts saySteven Grossman, a regulatory consultant at HPS Group and author of the FDA Matters newsletter, said in an email to CQ Roll Call that his concerns about the future of the user fee program have grown since...
Q&A – June 20, 2025

Featured in Regulatory Focus

DOGE claims $30M savings from canceling 30 FDA leasesThe Department of Government Efficiency (DOGE) this week claimed it had canceled 30 leases for US Food and Drug Administration (FDA) facilities nationwide, including a facility in St. Louis, MO, which is crucial to...
Q&A – June 20, 2025

Quoted in The Boston Globe

‘It’s shameful’: Silence on Robert F. Kennedy Jr. from major medical groups draws criticismThe Boston GlobeSteven Grossman, who recently retired from leading the FDA-funding advocacy group Alliance for a Stronger FDA, cited the endorsement decisions...